Back
Lumos Pharma Vs. Bio-Path Holdings Industry Stock Comparison
Sell
25
LUMO
Lumos Pharma
Last Price:
2.15
Seasonality Move:
-2.35%
Sell
8
BPTH
Bio-Path Holdings
Last Price:
1.71
Seasonality Move:
0.65%
Sell
25
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy, Sell or Hold?
- The current Lumos Pharma [LUMO] share price is $2.21. The Score for LUMO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- LUMO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Bio-Path Holdings (BPTH)
is a Sell
Is Bio-Path Holdings a Buy, Sell or Hold?
- The current Bio-Path Holdings [BPTH] share price is $1.71. The Score for BPTH is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- BPTH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LUMO Stock Price Chart
What is Lumos Pharma's stock price today?
-
The Lumos Pharma share price today is $2.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LUMO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPTH Stock Price Chart
What is Bio-Path Holdings's stock price today?
-
The Bio-Path Holdings share price today is $1.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing selling pressure, which indicates risk of future bearish movement.
LUMO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 40.39 | Sell |
Chaikin Money Flow: | 2380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.21 - 2.43) | Sell |
Bollinger Bands (100): | (2.4 - 2.98) | Sell |
BPTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 34.97 | Sell |
Chaikin Money Flow: | -31487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.66) | Sell |
Bollinger Bands (100): | (1.84 - 5.76) | Sell |
LUMO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.25 | Sell |
20-day SMA: | 2.33 | Sell |
50-day SMA: | 2.52 | Sell |
200-day SMA: | 2.97 | Sell |
8-day EMA: | 2.25 | Sell |
20-day EMA: | 2.31 | Sell |
50-day EMA: | 2.46 | Sell |
200-day EMA: | 2.94 | Sell |
BPTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.92 | Sell |
20-day SMA: | 2.13 | Sell |
50-day SMA: | 2.35 | Sell |
200-day SMA: | 6.85 | Sell |
8-day EMA: | 1.9 | Sell |
20-day EMA: | 2.09 | Sell |
50-day EMA: | 2.61 | Sell |
200-day EMA: | 8.4 | Sell |
Lumos Pharma Earnings Growth & LUMO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.56 per share, and an increase next year of $1.38 per share.
Bio-Path Holdings Earnings Growth & BPTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $27.87 per share, and an increase next year of $1.88 per share.
Lumos Pharma Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bio-Path Holdings Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |